Skip to main content
Premium Trial:

Request an Annual Quote

DNA2.0 to Open UK Office for European Synthetic Gene Market

NEW YORK (GenomeWeb News) – California-based gene synthesis firm DNA2.0 is expanding by opening an arm in the UK called DNA2.0 Ltd., the company said today.
The company, which supplies synthetic genes to academic and government customers, as well as companies in the pharmaceutical, biotechnology, chemical, agricultural fields, already has a European office in Basel, Switzerland.
"Even in a time of economic uncertainty, the market for gene synthesis and its many applications continues to grow rapidly in Europe,” DNA2.0 President Jeremy Minshull said in a statement.
The UK headquarters will be run by Michael Dyson, who has been appointed managing director of European operations and who runs the company’s Switzerland office.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.